Next Green Wave (CSE:NGW) (“Next Green Wave” or the “Company”), is pleased to provide an update on the advancement of its cannabis production facility, located in the community of Coalinga, California. The first phase of construction on the USD $8M state-of-the-art indoor facility is now 90% complete.
The 35,000 sq.ft. automated facility is equipped with proprietary fertigation, operational and security systems. The building will also encompass 18 positive pressured, climate-controlled rooms to accommodate the full cycle cannabis growth.
Key Facility Features
- Nursery: 6,500 sq.ft. space to accommodate seed and seedling production, cloning and creating premium hybrids
- Cultivation: 14,000 sq.ft. flowering space comprised of 18 grow rooms producing various premium strains of cannabis flower
- Post Harvest: Trimming, drying and curing areas
- Distribution: Transportation, sales, packaging
Cannot view this video? Visit:
Video: Interview with Mike Jennings + Facility Overview
In anticipation of commercial operations, Next Green Wave also held a well-attended job fair with the support of the local community and Coalinga Mayor, Nathan Vosburg. The Company is currently recruiting for 25+ positions for qualified gardeners, trimmers, security personnel, and administrative staff. (For full details on the fair please visit: CoalingPress_NGW_NewsArticle)
“We are laying a strong foundation for the company and our stakeholders, it has only been two weeks since NGW was publicly listed, and we are hitting all our benchmarks completing the groundwork and facility so that we can get into revenue as quickly as possible,” commented Executive Chairman Leigh Hughes. “We’re also taking proactive steps to strengthen our workforce and taking the opportunity to invest in the community in which we will be operating.”
ABOUT NEXT GREEN WAVE HOLDINGS INC.
Next Green Wave is a vertically integrated seed-to-consumer premium medicinal and recreational cannabis company operating in California, the world’s largest cannabis market. Led by award-winning cannabis industry veteran, Michael Jennings, who is an industry innovator specializing in developing premium cannabis seeds and plants and known throughout the cannabis culture in the state. NGW central operations are in Coalinga which is centered between two major markets of San Francisco and Los Angeles and has been awarded permits for nursery, cultivation, extraction, and distribution. The Company has acquired over 15 acres of cannabis-zoned development land and has nearly completed the construction of its first facility cannabis-zoned development land and has nearly completed the construction of its first facility. NGW is fully funded having raised over CAD $21M, to bring the company into revenue in 2019.
On behalf of the Board,
Executive Chairman, Next Green Wave Holdings Inc.
For information on Next Green Wave please visit www.nextgreenwave.com/investors. For copies of news releases and all company materials please refer to SEDAR (www.sedar.com). For all investor relations information, please refer to www.nextgreenwave.com/investors or contact IR@nextgreenwave.com or +1 778-589-5054.
Neither the Canadian Securities Exchange (the “CSE”) nor its Regulation Services Providers (as that term is defined in the policies of the CSE) accepts responsibility for the adequacy or accuracy of this release.
Certain statements contained in this press release constitute forward-looking information. These statements relate to future events or future performance. The use of any of the words “could”, “intend”, “expect”, “believe”, “will”, “projected”, “estimated” and similar expressions and statements relating to matters that are not historical facts are intended to identify forward-looking information and are based on the Company’s current belief or assumptions as to the outcome and timing of such future events. Actual future results may differ materially. In particular, this release contains forward-looking information relating to the intention of the parties to complete the Acquisition and certain ancillary transactions contemplated thereby. These transactions are subject to a number of material risks, and there is no assurance that they will be completed on the terms or within the timeframes currently contemplated, or at all. The forward-looking information contained in this press release is made as of the date hereof and the Company is not obligated to update or revise any forward-looking information, whether as a result of new information, future events or otherwise, except as required by applicable securities laws. Because of the risks, uncertainties and assumptions contained herein, investors should not place undue reliance on forward-looking information. The foregoing statements expressly qualify any forward-looking information contained herein.
Meanwhile, two longstanding cannabis partners ended their relationship.
Trulieve to donate $20,000 in scholarship funding and $15,000 to support leadership development
Trulieve Cannabis Corp . (CSE: TRUL) (OTC: TCNNF), a leading and top-performing cannabis company in the United States today announced a new partnership with the Thurgood Marshall College Fund (TMCF), the nation’s largest organization exclusively representing the Black College Community. Trulieve will donate $20,000 to help fund several college scholarships awarded to students who are attending one of the organization’s member-schools as part of Trulieve’s diversity, equity, and inclusion initiatives. The $15,000 in talent funding is earmarked to support TMCF’s internship program, reaching a diverse talent pool of students and alumni from their 47 member-schools to provide immersive experiences at Trulieve.
The new dispensary expands patient access to Florida’s largest inventory of medical cannabis products
Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) (“Trulieve” or “the Company”), a leading and top-performing cannabis company based in the United States announced today the opening of a brand-new Florida dispensary, the Company’s 80th nationwide. The new location marks the Company’s first in Tamarac and third in Broward County expanding patient access to Florida’s largest and broadest assortment of high-quality medical cannabis products.
Revive Therapeutics Provides Update on FDA Phase 3 Clinical Trial for Bucillamine in COVID-19 with Planned Completion and Emergency Use Authorization Request
Revive Therapeutics Ltd. (“Revive” or the “Company”) (CSE: RVV, USA: RVVTF), a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders, is pleased to announce an update on the Company’s U.S. Food & Drug Administration (“FDA”) Phase 3 clinical trial (the “Study”) to evaluate the safety and efficacy of Bucillamine in patients with mild to moderate COVID-19.
With its recent $23 million dollar financing, the Company plans to aggressively expand from 14 clinical sites to up to 50 clinical sites to meet the next enrollment goals for the Study in Q2-2020. The Study is a randomized, double-blinded, placebo-controlled trial and the safety and efficacy data analyzed at each interim analysis timepoint of 210, 400, 600 and 800 completed patients are only made available to the Independent Data and Safety Monitoring Board (“DSMB”) for review and recommendations on continuation, stopping or changes to the conduct of the Study. In the event of any serious safety concerns, the DSMB would be notified to determine any risks and provide its recommendations. To date, in this initial 210 interim point there have been no serious safety concerns that required the DSMB to be notified.
HempFusion Wellness Inc. (TSX:CBD.U) (OTCQX:CBDHF) (FWB:8OO) (“HempFusion” or the “Company”), a leading health and wellness CBD company utilizing the power of whole-food hemp nutrition, is pleased to announce that its common shares have been approved for DTC full-service eligibility in the United States by the Depository Trust Company (“DTC”) and can now be both traded and serviced through DTC’s electronic book-entry system.
DTC is a subsidiary of the Depository Trust & Clearing Corp. (“DTCC”) that provides clearing and settlement services for the financial markets and settles the majority of securities transactions in the United States. This electronic method of clearing securities speeds up the receipt of stock and cash and thus accelerates the settlement process for investors and brokers, enabling the stock to be traded over a much wider selection of brokerage firms.